Precision medicine is part of the logical evolution of contemporary evidence-based medicine
that seeks to reduce errors and optimize outcomes when making medical decisions and …

Obesity and type 2 diabetes are causally related, yet there is considerable heterogeneity in
the consequences of both conditions and the mechanisms of action are poorly defined. Here …

We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing
2,973 individuals across three molecular classes, metabolites, lipids and proteins. …

The detailed characterization of human biology and behaviors is now possible at scale
owing to innovations in biomarkers, bioimaging, and wearable technologies; “big data” from …

Introduction: Since 2005, disease-related human genetic diversity has been intensively
characterized using genome-wide association studies (GWAS). Understanding how and by …

Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious
health complications in individuals with and without type 2 diabetes (T2D). Early diagnosis …

Aims/hypothesis Five clusters based on clinical characteristics have been suggested as
diabetes subtypes: one autoimmune and four subtypes of type 2 diabetes. In the current study …

Type 2 diabetes is a multifactorial disease with multiple underlying aetiologies. To address
this heterogeneity, investigators of a previous study clustered people with diabetes according …

The app-based COVID Symptom Study was launched in Sweden in April 2020 to contribute
to real-time COVID-19 surveillance. We enrolled 143,531 study participants (≥18 years) …

Background Precision medicine has the potential to improve cardiovascular disease (CVD)
risk prediction in individuals with Type 2 diabetes (T2D). Methods We conducted a …